investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Regulating the Immune Microenvironment in Breast Cancer
Lisa M Coussens
2 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Michele De Palma
San Raffaele Hospital (IRCCS)
Milan, Italy
Donal Brennan
University College Dublin
Dublin, Ireland
Lisa M Coussens
Oregon Health & Science University
Portland, United States
Related projects
Andre Michael Lieber
Hematopoietic stem cell based gene therapy of breast cancer
Breast
Ajit P Varki
Oligosaccharies of Normal and Malignant Cells
Breast
Maxwell Lee
Genetics and Epigenetics of Cancer
Breast
Hans Schreiber
Immunology of Unique Tumor Specific Antigens
Breast
Dihua Yu
Stromal activation in the progression of high ErbB2/1433zeta DCIS to IBC
Breast
Carol A Lange
Inducible PTK6 expression drives oncogenic signaling in breast cancer
Breast
Joshua Labaer
Biomarker Detection Using NAPPA Tumor Antigen Arrays
Breast
Ming Tan
Glucose Metabolism and ErbB2-Mediated Cancer Progression
Breast
Powel Brown
A MULTICENTER PHASE II STUDY OF DOCOSAHEXAENOIC ACID IN PATIENTS WITH A HISTORY OF BREAST CANCER, PREMALIGNANT LESIONS, OR BENIGN BREAST DISEASE
Breast
